Predictions
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.20
28.06.24
28.06.24
-
28.06.25
28.06.25
-12.36%
06.07.24
06.07.24
Risky Investment
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.76
27.05.24
27.05.24
-
27.05.25
27.05.25
-9.24%
09.06.24
09.06.24
Probably not worthwhile Investment
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.62
27.05.24
27.05.24
-
27.05.25
27.05.25
-30.80%
08.06.24
08.06.24
Probably not worthwhile Investment
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.05
30.05.24
30.05.24
-
30.05.25
30.05.25
22.20%
08.06.24
08.06.24
Could be very worthwhile Investment >20% year
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€5.79
28.05.24
28.05.24
-
28.05.25
28.05.25
-56.74%
08.06.24
08.06.24
Good culture
Risky Investment
No uniques
Nanorepro AG
Start price
Target price
Perf. (%)
€9.94
29.11.21
29.11.21
-
29.11.25
29.11.25
-83.35%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
CytoTools AG
Start price
Target price
Perf. (%)
€1.15
28.11.22
28.11.22
-
28.11.23
28.11.23
91.30%
24.04.23
24.04.23
Probably not worthwhile Investment
Nanorepro AG
Start price
Target price
Perf. (%)
€6.38
10.01.22
10.01.22
€7.50
10.01.23
10.01.23
-64.19%
10.01.23
10.01.23
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€18.36
27.11.21
27.11.21
€19.00
27.11.22
27.11.22
-50.44%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
CytoTools AG
Start price
Target price
Perf. (%)
€8.50
01.11.21
01.11.21
-
01.11.22
01.11.22
-78.94%
02.11.22
02.11.22
Probably not worthwhile Investment
Nanorepro AG
Start price
Target price
Perf. (%)
€3.97
27.07.22
27.07.22
€15.00
27.08.22
27.08.22
-14.12%
28.08.22
28.08.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Very high dividend yield expected
Top 10 in its market
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€4.84
10.07.22
10.07.22
€7.00
10.07.23
10.07.23
19.42%
23.07.22
23.07.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Vivoryon Therapeutics N.V.
Start price
Target price
Perf. (%)
€19.50
06.01.22
06.01.22
-
06.01.23
06.01.23
-45.13%
13.03.22
13.03.22
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€8.98
21.02.21
21.02.21
€10.00
21.02.22
21.02.22
-54.90%
22.02.22
22.02.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Nanorepro AG
Start price
Target price
Perf. (%)
€3.38
26.11.20
26.11.20
-
16.11.21
16.11.21
198.22%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€2.68
16.03.20
16.03.20
€3.00
04.11.21
04.11.21
120.15%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Nanorepro AG
Start price
Target price
Perf. (%)
€8.95
16.02.21
16.02.21
€5.00
16.02.22
16.02.22
-7.49%
18.10.21
18.10.21
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Nanorepro AG
Start price
Target price
Perf. (%)
€8.60
15.02.21
15.02.21
€20.00
15.02.22
15.02.22
5.47%
23.09.21
23.09.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Nanorepro AG
Start price
Target price
Perf. (%)
€16.00
12.03.21
12.03.21
€22.00
12.03.22
12.03.22
-62.19%
12.08.21
12.08.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business